Sorafenib in combination with transarterial chemoembolization for the treatment of hepatocellular carcinoma.

Sorafenib in combination with transarterial chemoembolization for the treatment of hepatocellular carcinoma. Clin Adv Hematol Oncol. 2016 Aug;14(8):585-7 Authors: Geschwind JF, Chapiro J PMID: 27487101 [PubMed - in process]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research